HIV, human immunodeficiency virus causes HIV-infection. The last stage of HIV-infection is known as Acquired Immune Deficiency Syndrome (AIDS). This disease carries away many people worldwide every year. Unfortunately, the medication for treatment of this disease has not been designed yet. AIDS distribution is great and the scientists in the whole world try to discover a drug to overcome AIDS. The treatment with anti-retroviral medications started in due time may stop HIV-infection progression and delay development to AIDS. The scientists have discovered some ways not to cure, but to delay the clinical course. This remedy is Atripla. Atripla is the first drug consisting of three anti-retroviral medications. The combination of three medications helps to increase Atripla efficiency and action.
After long clinical trials and investigations of Atripla the drug manufacturers Gilead Sciences and Bristol-Myers Squibb have been approved by the Food and Drug Administration of the USA to launch it at the market. Since July 12, 2006 Atripla is available for people and is successfully used in medicine. We’d like to consider the drug more thoroughly to understand if the drug components are good enough to fight such a serious virus.

HIV (Acquired Immune Deficiency Syndrome) is a slowly progressing infectious disease characterized by immune system disorder and various clinical symptoms. For today, HIV occupies a special place in medicine. HIV is one of the most dangerous diseases which not only breaks lives of people, but also carries them away. The fight against HIV continues many years and during these years the scientists around the world have been trying to find a drug to overcome this disease. Unfortunately, the medication which will definitively relieve people from HIV infection has not been designed yet, but progressive medicine has developed medications inhibiting infection growth in the organism that helps to prolong the life of the patients. One of these medications is Truvada.